Omvoh

Omvoh (mirikizumab) is a prescription medication used to treat Ulcerative colitis. A biologic for adults with moderately to severely active ulcerative colitis, an inflammatory bowel disease affecting the colon.

Blocks interleukin-23 (IL-23), a protein that fuels the inflammation behind ulcerative colitis.

Commonly reported side effects of Omvoh include Upper respiratory infections, Injection site reactions, Headache, and Joint pain. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Omvoh has notable warnings and precautions. Tell your doctor about your medical history and any other medicines or supplements you take before starting Omvoh.

The active ingredient in Omvoh is mirikizumab, which belongs to a class of medicines known as IL-23 Inhibitor (Biologic).

Omvoh is manufactured by Eli Lilly. It was first approved in 2023.

You may be able to lower the cost of Omvoh by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.